APHP URCo
"The European Patients" Academy on Therapeutic Innovation (EUPATI) provides education
and training for patients and patient representatives on the process of medicines research
and development (R&D). The trained patient experts are key to realising meaningful patient
engagement in medicines R&D, regulatory deliberations and other activities.
EUPATI was established by the Innovative Medicines Initiative (IMI) in 2012, and was hosted
by the European Patients' Forum (EPF) as a Public-Private Partnership Programme 2017-
2020.
EUPATI is today established as an independent non-profit Foundation in the Netherlands and
has 24 National Platforms in Europe and in Japan.
"We focus on education and training to increase the capacity and capability of patients to be valuable contributors to medicines research and development by working with patients andthe stakeholders they collaborate with."
Role
URC Eco will participate in the econmic evalaution of the clinical trial.
Members
Isabelle Durand-Zaleski
Isabelle Durand-Zaleski is a medical doctor, Professor in Public Health.
She carried out her PhD research in economics and management at Paris IX
University. She holds a Masters in Public Health from Harvard University and a
diploma from the Political Study Institute of Paris (Institut d’Etudes Politiques
de Paris). She has been the head of the Evaluation Department in the National
Health Authority. She is currently the head of the Paris Health Economics and
Health Services Research Unit in Paris.